Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00402480
First received: November 21, 2006
Last updated: June 17, 2013
Last verified: November 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2006
  Estimated Primary Completion Date: No date given